Clinical Trials List
Protocol NumberM20-124
NCT Number(ClinicalTrials.gov Identfier)-
Active
2020-08-01 - 2025-07-01
Phase I
Not yet recruiting1
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/24
Investigators and Locations
Principal Investigator
Chia-Chi Lin
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐偉勛
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
-- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
280 participants
